News & Events


Recent Firm Activities and Highlights

Boston Millennia Parters
Dana Callow to speak at the 30th MedTech Investing Europe Conference Virtual Event 21-22 October 2020
10.22.20
Migraine and cataract therapies and a transit solution for vaccines such as Covid-19 are among the new cutting-edge innovations to be presented in the virtual 30th MedTech Investing Europe Conference on 21-22 October, 2020. Campden Wealth organisers said attendees will be able to participate online and benefit from everything the MedTech Investing events normally offered—industry leading content, speakers from some of the world’s foremost investors and dedicated networking for both investors and presenting companies. Attendees were required to pre-register and will receive full details, access links and schedule in advance of the event. Read Full Release
Boston Millennia Parters
Dana Callow to speak at Opal’s Family Office & Private Wealth Management Forum in Newport 7.23.19
07.10.19
As Opal Financial Group’s flagship event, The Family Office & Private Wealth Management Forum has become Opal’s largest family office event in the world. Known for its rich history and magnificent mansions, Newport, RI attracts thousands of delegates each year. The voyage begins with an annual Regatta Cup race, giving delegates an opportunity to find their inner competitor, and race across the harbor. In the course of three days, family offices, private investors, and investment managers navigate their way through the choppy waters of the past recession, while continuing to explore the best ways to map out their portfolios. With over 1000 delegates there is always an opportunity to meet potential clients. Discussions will cover a wide variety of investment topics including direct investing, impact investing, non-correlated assets, and many more. Come join us this July-- the forecast calls for fun, networking, and favorable prospects for preserving your family’s wealth. Read Full Release
Boston Millennia Parters
Dana Callow to be Panelist at Funding Models in Biotech MBBP Life Sciences Series – Panel 3
09.22.16
Today’s financing environment for emerging biotech companies presents a number of challenges. Venture capital funds are ever more cautious about taking risk, and some players have departed the field at the early stage. Government grants have also closed their spigots in recent years, as the volume of government funding has plummeted dramatically. However, new players have entered the fray in the last few years, including family offices, super angels, strategic partners and foreign investors, replacing the investment dollars previously offered by institutional investors. So where does an emerging biotech company forage for precious dollars? Come join us on September 22nd at the CIC in Cambridge to hear a panel of experts discuss these trends. At the event, you will discover, among other ideas: Where and how to find the new players; What areas of interest are these players financing; How to optimize your chances of success; What are deal structures looking like? Read Full Release
Boston Millennia Parters
David Carney to Attend CED Tech Venture Conference
09.13.16
From early startups to growth-stage companies to highly successful businesses, the CED Tech Venture Conference reflects North Carolina’s vibrant entrepreneurial community and showcases many of the most-promising emerging companies in the region. Attendees will have the opportunity to connect with a diverse group of over 100 investors, from venture capital to corporate to angels, including funds such as Sequoia Capital, Greycroft, Grotech Ventures, and Comcast Ventures. Engage with industry leaders, radical thinkers and trail-blazing entrepreneurs, and learn about the disruptive innovations that are transforming the ways in which we live, work and play. Read Full Release
Boston Millennia Parters
Dana Callow to be on Lifescience Panel at the Richi Immersion Summer 2016 Program
07.21.16
Richi Social Entrepreneurs is a Richi Foundation initiative whose mission is to foster and catalyze the development of international Social Entrepreneurship ecosystems, taking Boston's unique case as our role model. Richi Social Entrepreneurs Immersion Summer 2016 is a one-month eye-opening experience in Boston. Social Entrepreneurs have the opportunity to explore Boston's advanced Social Innovation ecosystems, while working on their social value proposition and problem-solution fit. Social Entrepreneurs wear different hats, from startup founders in BioTech, HealthCare or Education, to professionals working in IT, CleanTech or Finance. It's not the industry that determines a project's potential social impact, it's the drive and motivation of the entrepreneur behind the idea. Read Full Release
Boston Millennia Parters
Dana Callow to Speak at Cancer Moonshot Summit
06.29.16
Boston Millennia Partners’ Dana Callow to Speak at Cancer Moonshot Summit. Simultaneous events will take place at the same time throughout the country to improve awareness of the program and gain support for funding research. Representatives from major pharmaceutical companies and service providers including Takeda, Syapse, and Foundation Medicine well as researchers from the area will speak about the Moonshot and their roles in finding a cure. The White House is sponsoring The National Cancer Moonshot summit. Vice President Joe Biden will speak on behalf of the program and subsequently there will be panel discussions by leading cancer specialists and patient advocates. As a Board Member of the National Leukemia Society Dana will address how non-profit organizations can positively impact the effort to find cures and improve patient care. Location: MGH Cancer Center, Lawrence House, 1st Floor Conference Room, 10 North Grove St., Boston MA Please contact liz@bmpvc.com for the speaker guide Read Full Release
PAREXEL International
PAREXEL Experts to Discuss Key Drug Development Insights at DIA 2016
06.20.16
BOSTON, June 20, 2016— PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that several of its experts will discuss key issues facing the industry at the 52nd Annual Drug Information Association (DIA) meeting, held from June 26-30, 2016 in Philadelphia. Read Full Release
PAREXEL International
PAREXEL Announces Master Services Agreement with Pfizer
06.10.16
BOSTON, June 10, 2016 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has signed a services agreement with Pfizer Inc. Under the terms of this agreement, PAREXEL will continue to provide global clinical research and development services to Pfizer in support of clinical development programs across its portfolio. Terms of the agreement were not disclosed. Read Full Release
PAREXEL International
PRXL to Present at Cambridge Healthtech Institute’s Twelfth Annual Biomarkers & Diagnostics World Congresss 2016
05.18.16
Presentation: Wednesday, May 18 - 9:20 am Extending Precision Medicine Beyond Oncology Arlene Hughes, Senior Director, Genomic Medicine, Clinical Research Services Visit PAREXEL at Booth 4 in the Exhibit Hall. Read Full Release
Boston Millennia Parters
Three NJ Startups Compete in Latest TechUnited:NJ STARTUP SHOWDOWN
09.22.20
Three tech startups from various parts of the Garden State competed in a Startup Showdown last week that focused on real-world data and evidence collection. The Startup Showdowns are presented by TechUnited:NJ (New Brunswick) and Tech Council Ventures (Summit) and hosted by Jasmine Hoffman. Pitching were Daniel Ferrara, founder and CEO of Roseland-based WellCare Today; Luke Malanga, COO of Cedar Knolls-based DataBiologics; and Kirsten Hund Blair, cofounder and CEO of Princeton-based Lambent Data. The investors who gave feedback were: Mark Kolb, entrepreneur in residence, Tech Council Ventures, who focuses on the healthcare industry; Steven Cohen, partner, Morgan Lewis (Philadelphia), who is chair of the Morgan Lewis emerging business and technology practice and an angel investor; and Ren Roome, principal, Boston Millennia Partners. The complete video of the program can be found here. For this episode, Lambent Data took home the audience choice award. Read Full Release
2020 MedTech Breakthrough Awards Recognize COTA as the Best Overall Medical Data Solution Provider
05.18.20
Boston, MA – May 18, 2020 – COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, is pleased to announce that MedTech Breakthrough has named COTA as a winner in the fourth annual MedTech Breakthrough Awards program for the “Best Overall Medical Data Solution Provider" award. The MedTech Breakthrough Awards recognize the top companies, people, platforms, and products in various industries including health, fitness, and medi Read Full Release
Boston Millennia Parters
Dana Callow to speak at Opal’s Family Office & Private Wealth Management Forum in Newport 7.23.19
07.10.19
As Opal Financial Group’s flagship event, The Family Office & Private Wealth Management Forum has become Opal’s largest family office event in the world. Known for its rich history and magnificent mansions, Newport, RI attracts thousands of delegates each year. The voyage begins with an annual Regatta Cup race, giving delegates an opportunity to find their inner competitor, and race across the harbor. In the course of three days, family offices, private investors, and investment managers navigate their way through the choppy waters of the past recession, while continuing to explore the best ways to map out their portfolios. With over 1000 delegates there is always an opportunity to meet potential clients. Discussions will cover a wide variety of investment topics including direct investing, impact investing, non-correlated assets, and many more. Come join us this July-- the forecast calls for fun, networking, and favorable prospects for preserving your family’s wealth. Read Full Release
COTA to attend ASCO May 31st – June 4th, 2019
05.31.19
Attending #ASCO19 5/31-6/4? Stop by Booth #2063 to learn how COTA organizes fragmented, often hidden data from the real world to provide a clear view of cancer or schedule a demo with us here: meetus@cotahealthcare.comFind more details about the attending here. Read Full Release
MedAptus to Attend AONE Annual Conference
04.10.19
AONE provides nurse leader education programs for executives, directors, managers and clinical leaders. Topics range from health care finance, CENP and CNML review courses, shared governance and emerging leader competencies. AONE's annual meeting has over 50 concurrent sessions as well as multiple nationally known keynote speakers. Continuing education credits is available for most AONE programs. Read Full Release
COTA
HIMSS19: The Importance of Data and Managing Expectations
02.01.19
It’s that time of year again! As we get ready for all that HIMSS has to offer and learn about exciting opportunities in healthcare, it’s important to manage expectations around what is going to be accomplished at the conference. It’s no surprise that HIMSS continues to get bigger and bigger every year, but many of the same things are still being discussed - Artificial Intelligence (AI), Machine Learning, Natural Language Processing, data security and improving efficiencies, to name a few. Read Full Release
COTA
HIMSS18: Interview with Stuart Goldberg, M.D. | Cota | Precision Payment
03.29.18
On this episode we talk with Stuart Goldberg, MD, Chief Scientific Officer at Cota. Dr. Goldberg tells us all about Cota’s physician-led journey to organize and classify real-world evidence about every type of cancer. This effort led to something they call the Cota Nodal Address (CNA), and it’s enabling health systems to get very specific about the types of patients they’re treating, the costs associated with them, and the outcomes being achieved. This apples-to-apples comparison allows Cota to identify variation and address it in ways that are beneficial to the provider, payer and patient. It enables a concept Dr. Goldberg calls “Precision Payment”, which in turn enables proper bundled payment design, and precision medicine. Read Full Release
Odyssey Logistics & Technology
Odyssey Logistics & Technology Receives Equity Investment from The Jordan Company
08.30.17
Odyssey Logistics & Technology Corporation (Odyssey), a leading global logistics provider, announced today that an affiliate of The Jordan Company has signed a definitive agreement to become the new majority shareholder in Odyssey. Read Full Release
Boston Millennia Parters
Dana Callow to Attend Harvard Medical School’s Precision Medicine 2017: Breakaway Business Models
06.21.17
In this year’s conference on Wednesday, June 21 (agenda below), we address the question of how to implement and disseminate these business models head on. Fortunately there are already several enterprises, some of them led by patients themselves, which provide us early answers to these questions. These are featured in our first panel entitled Early Disruptors in Precision Medicine. Read Full Release
Boston Millennia Parters
LifeScan Partners with Cecelia Health to Provide Personalized Diabetes Health Management Coaching for OneTouch® Consumers
11.01.20
LifeScan, a world leader in blood glucose monitoring, serving 20 million people with diabetes and the maker of the iconic OneTouch® brand products, and Cecelia Health, one of the nation's most scalable clinical coaching and telehealth companies focused on diabetes and other chronic disease management, today announced a partnership to deliver best-in-class, live, personalized coaching from Cecelia Health's Certified Diabetes Care and Education Specialists through our OneTouch Reveal app beginning November 2020. Read More
Boston Millennia Parters
STUDY IN NATURE MEDICINE SHOWS SUPERIOR OUTCOMES FOR PATIENTS IN LLS’S PARADIGM-SHIFTING BEAT AML CLINICAL TRIAL
10.26.20
Patients participating in The Leukemia & Lymphoma Society’s (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature Medicine journal. The Beat AML trial achieved its primary endpoint by showing genomic analysis of the leukemia cells to identify AML subtypes can be completed within an unprecedented seven days, giving patients, caregivers and their doctors ample time to make a more personalized treatment decision without risking the patient’s chance for survival. Read More
Boston Millennia Parters
Three NJ Startups Compete in Latest TechUnited:NJ STARTUP SHOWDOWN
09.22.20
Three tech startups from various parts of the Garden State competed in a Startup Showdown last week that focused on real-world data and evidence collection. The Startup Showdowns are presented by TechUnited:NJ (New Brunswick) and Tech Council Ventures (Summit) and hosted by Jasmine Hoffman. Pitching were Daniel Ferrara, founder and CEO of Roseland-based WellCare Today; Luke Malanga, COO of Cedar Knolls-based DataBiologics; and Kirsten Hund Blair, cofounder and CEO of Princeton-based Lambent Data. The investors who gave feedback were: Mark Kolb, entrepreneur in residence, Tech Council Ventures, who focuses on the healthcare industry; Steven Cohen, partner, Morgan Lewis (Philadelphia), who is chair of the Morgan Lewis emerging business and technology practice and an angel investor; and Ren Roome, principal, Boston Millennia Partners. The complete video of the program can be found here. For this episode, Lambent Data took home the audience choice award. Read More
Stay up to date with COTA’s Real World Talk Podcast
09.16.20
The Evolving Relationship Between Real World Data and Clinical Trials with Nancy Dreyer and C.K. Wang In this episode of Real World Talk, host Zoe Li talks to Nancy Dreyer, Chief Scientific Officer of IQVIA, and COTA’s own Chief Medical Officer, Dr. C.K. Wang. They discuss the interactions between real world data and clinical trials, and how the two approaches can complement each other. They also look at why the Lancet retracted a large study into the use of hydroxychloroquine to treat COVID-19 in June, after questions were raised about its curation and application of real world data. Read More
Boston Millennia Parters
Digital Diagnostics, formerly IDx, Expands Global Impact of Healthcare Autonomous AI with Acquisition of 3Derm Systems, Inc.
08.19.20
Healthcare access and inequity challenges have been exacerbated by the COVID-19 pandemic; members of at-risk populations around the world are increasingly delaying important specialist care. Today Digital Diagnostics Inc., a pioneering global healthcare autonomous artificial intelligence (AI) company formerly known as IDx, announces it has acquired 3Derm Systems, Inc. of Boston, MA. This acquisition makes Digital Diagnostics the global leader in healthcare autonomous AI, where it is the sole holder of autonomous AI healthcare systems that are De Novo authorized by the U.S. Food & Drug Administration (FDA), enabling the company to close more care gaps widened by COVID-19. Read More
IBM Watson Health and OrbitalRX to Launch Integrated Solution to Assist Hospital Pharmacy Providers in Managing Drug Shortages
09.01.20
IBM (NYSE: IBM) Watson Health and OrbitalRX® today announced a strategic collaboration that aims to help address the emerging drug shortage crisis. The companies are combining OrbitalRX's Drug Shortage Management Platform and IBM® Micromedex® into one unified solution called "OrbitalRX and Micromedex," designed to create a single source for healthcare providers and pharmacy teams to access evidence-based treatment information alongside a hospital's current drug inventory status and drug sourcing options. This one solution aims to quickly analyze the supply chain and identify clinical alternatives for drugs that are in short supply. Read More
medaptus Celebrates 20 Years of Health Technology Innovation
08.23.20
For 20 years medaptus has applied information technology to solve problems that are common and costly to healthcare organizations. To mark its twentieth anniversary, the company recently provided an update on its extensive technology capabilities grounded in interoperability. Read More
Boston Millennia Parters
Digital Diagnostics, formerly IDx, Expands Global Impact of Healthcare Autonomous AI with Acquisition of 3Derm Systems, Inc.
08.23.20
Healthcare access and inequity challenges have been exacerbated by the COVID-19 pandemic; members of at-risk populations around the world are increasingly delaying important specialist care. Today Digital Diagnostics Inc., a pioneering global healthcare autonomous artificial intelligence (AI) company formerly known as IDx, announces it has acquired 3Derm Systems, Inc. of Boston, MA. This acquisition makes Digital Diagnostics the global leader in healthcare autonomous AI, where it is the sole holder of autonomous AI healthcare systems that are De Novo authorized by the U.S. Food & Drug Administration (FDA), enabling the company to close more care gaps widened by COVID-19. Read More
Boston Millennia Parters
EY Announces David Weingard of Cecelia Health as an Entrepreneur Of The Year® 2020 New York Award Finalist
08.19.20
Ernst & Young LLP (EY US) has announced that David Weingard, CEO and Founder of Cecelia Health, was named an Entrepreneur Of The Year® 2020 New York Award finalist. Now in its 34th year, the Entrepreneur Of The Year program honors entrepreneurial business leaders whose ambitions deliver innovation, growth and prosperity as they build and sustain successful businesses that transform our world. David was selected as one of the finalists by a panel of independent judges comprising former winners and business leaders from multiple industries. Read More
Boston Millennia Parters
Cecelia Health Completes $13 Million Series B Financing to Transform Lives of People Living with Diabetes and Other Chronic Conditions
08.13.20
Cecelia Health, a leading technology-enabled diabetes and other chronic disease management company, announced today it has completed a $13 million Series B funding round. The investment was co-led by Rittenhouse Ventures and Endo Investors, and includes investments from Boston Millennia Partners, SustainVC, G100 Capital, and others. The funding will enable the company to accelerate and further scale the adoption of the company's technology enabled coaching and telemedicine solutions and expand Cecelia Health’s digital health capabilities. Read More
Boston Millennia Parters
LifeScan Partners with Cecelia Health to Provide Personalized Diabetes Health Management Coaching for OneTouch® Consumers
11.01.20
LifeScan, a world leader in blood glucose monitoring, serving 20 million people with diabetes and the maker of the iconic OneTouch® brand products, and Cecelia Health, one of the nation's most scalable clinical coaching and telehealth companies focused on diabetes and other chronic disease management, today announced a partnership to deliver best-in-class, live, personalized coaching from Cecelia Health's Certified Diabetes Care and Education Specialists through our OneTouch Reveal app beginning November 2020. Read Full Release
Boston Millennia Parters
Digital Diagnostics, formerly IDx, Expands Global Impact of Healthcare Autonomous AI with Acquisition of 3Derm Systems, Inc.
08.19.20
Healthcare access and inequity challenges have been exacerbated by the COVID-19 pandemic; members of at-risk populations around the world are increasingly delaying important specialist care. Today Digital Diagnostics Inc., a pioneering global healthcare autonomous artificial intelligence (AI) company formerly known as IDx, announces it has acquired 3Derm Systems, Inc. of Boston, MA. This acquisition makes Digital Diagnostics the global leader in healthcare autonomous AI, where it is the sole holder of autonomous AI healthcare systems that are De Novo authorized by the U.S. Food & Drug Administration (FDA), enabling the company to close more care gaps widened by COVID-19. Read Full Release
What is Hospital Charge Reconciliation?
09.15.20
Working in and around revenue cycle technology for so long, we often communicate about features and benefits in shorthand. With so many different types of health information solutions, ownership models, service lines and so forth, sometimes we talk about things in an unknown, or jargon-y language without even realizing it. Take charge reconciliation as an example. At medaptus this means the act of confirming that for every visit and/or service delivered, a charge exists. When it doesn’t, this is evident and actionable. Charge reconciliation is vital to all of our products. Read Full Release
Boston Millennia Parters
Digital Diagnostics, formerly IDx, Expands Global Impact of Healthcare Autonomous AI with Acquisition of 3Derm Systems, Inc.
08.23.20
Healthcare access and inequity challenges have been exacerbated by the COVID-19 pandemic; members of at-risk populations around the world are increasingly delaying important specialist care. Today Digital Diagnostics Inc., a pioneering global healthcare autonomous artificial intelligence (AI) company formerly known as IDx, announces it has acquired 3Derm Systems, Inc. of Boston, MA. This acquisition makes Digital Diagnostics the global leader in healthcare autonomous AI, where it is the sole holder of autonomous AI healthcare systems that are De Novo authorized by the U.S. Food & Drug Administration (FDA), enabling the company to close more care gaps widened by COVID-19. Read Full Release
Boston Millennia Parters
EY Announces David Weingard of Cecelia Health as an Entrepreneur Of The Year® 2020 New York Award Finalist
08.19.20
Ernst & Young LLP (EY US) has announced that David Weingard, CEO and Founder of Cecelia Health, was named an Entrepreneur Of The Year® 2020 New York Award finalist. Now in its 34th year, the Entrepreneur Of The Year program honors entrepreneurial business leaders whose ambitions deliver innovation, growth and prosperity as they build and sustain successful businesses that transform our world. David was selected as one of the finalists by a panel of independent judges comprising former winners and business leaders from multiple industries. Read Full Release
Boston Millennia Parters
Cecelia Health Completes $13 Million Series B Financing to Transform Lives of People Living with Diabetes and Other Chronic Conditions
08.13.20
Cecelia Health, a leading technology-enabled diabetes and other chronic disease management company, announced today it has completed a $13 million Series B funding round. The investment was co-led by Rittenhouse Ventures and Endo Investors, and includes investments from Boston Millennia Partners, SustainVC, G100 Capital, and others. The funding will enable the company to accelerate and further scale the adoption of the company's technology enabled coaching and telemedicine solutions and expand Cecelia Health’s digital health capabilities. Read Full Release
TrekIT Health Raises $1M in Seed Funding
07.28.20
TrekIT Health, a Philadelphia, PA-based company re-designing the EHR experience for clinicians through predictive data visualization and modern clinical workflow tools, closed $1M in additional seed financing. The round was led by Tech Council Ventures with participation from Boston Millennia Partners Founders Fund and Front Row Fund, who joined existing investors including IP Group, DreamIT Health and Ben Franklin Technology Partners of Southeastern PA. Read Full Release
COTA Supports FDA Assessment of Real-World Data through Membership in COVID-19 Evidence Accelerator
06.10.20
COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, is pleased to announce a number of initiatives that are bringing enhanced understanding of COVID-19 in near real-time. Leveraging its past knowledge of real-world evidence applications and learnings, COTA has joined the COVID-19 Evidence Accelerator program, a joint initiative of Friends of Cancer Research (Friends) and the Reagan-Udall Foundation for the Food and Drug Administration. Through this initiative, COTA is delivering findings from its observational, real-world studies using data from over 3,000 patients hospitalized with COVID-19 within the Hackensack Meridian Health network. Read Full Release
BC Platforms and Kaiser Permanente Win 2020 Microsoft Health Innovation Award for Precision Medicine Collaboration
05.19.20
BC Platforms and Kaiser Permanente today announced they are winners of the 2020 Microsoft Health Innovation Award in the Reimagine Health Category for enabling a unique way of pairing clinical and genomic data on the same platform to advance precision medicine capabilities. Read Full Release
Reveleer COVID-19 Business Continuity Update
04.01.20
Dear friends, As the world continues to rapidly change around us due to Coronavirus (COVID-19), we wanted to reach out to our partners, and prospective partners, to let you know what to expect from Reveleer during this challenging time.First and foremost, our thoughts go out to those who have been directly impacted by COVID-19 and those working on the front lines to treat and control the spread of illness.... Read Full Release